Pipeline

Programs built on visual biology

Our pipeline combines in-house programs with partnered discovery across oncology, neuroscience and immunology.

ANB-101
MYC translation modulator
Oncology
In-house
ANB-204
TDP-43 accumulation
Neuroscience
In-house
ANB-212
SOD1 mRNA regulation
Neuroscience
In-house
ANB-305
Inflammatory cytokine program
Immunology
In-house
Partner program A
mRNA-targeted small molecules
Oncology
Lilly
Partner program B
Undisclosed targets
Neuroscience
Takeda
Partner program C
Oncology & immunology targets
Immunology
AbbVie

Mockup content: program names, targets and stages are placeholders, not disclosed pipeline data.

Therapeutic focus

Where visual biology makes the difference

Oncology

Undruggable drivers

Reach oncogenic proteins through the cellular processes that control them, such as translation and mRNA regulation.

Neuroscience

Protein homeostasis

Track aggregation and clearance in neurons, including TDP-43 and SOD1 biology relevant to ALS.

Immunology

Immune signaling

Profile how molecules reshape inflammatory pathways across immune cell types.

Partner on a program

We co-develop programs with pharma partners from target to candidate.

Discuss partnering